Literature DB >> 14702251

Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus.

Joel Gelernter1, Grier P Page, Murray B Stein, Scott W Woods.   

Abstract

OBJECTIVE: Social phobia is a common, sometimes disabling, fear of situations that might entail scrutiny by others. Several anxiety disorders, including social phobia, are genetically influenced. Genetic linkage analysis can provide the means to identify genomic locations harboring susceptibility loci for genetically influenced disorders. Identifying loci for social phobia was the goal of this study.
METHOD: The authors conducted a genome-wide linkage scan, i.e., tested enough genetic markers to query the entire genome, in 17 American pedigrees (163 subjects) ascertained through probands with panic disorder. Several anxiety disorders segregate in these families; diagnoses were based on structured interviews. A total of 422 markers (404 autosomal, 18 on the X chromosome) with an average spacing of less than 10 centimorgans were genotyped. Multipoint lod score and nonparametric (Zlr score) linkage analyses for social phobia were completed with Allegro and Genehunter X software.
RESULTS: Evidence for linkage to social phobia for chromosome 16 markers was identified. A Zlr score of 3.41 was observed for chromosome 16 near marker D16S415. The maximum observed lod score was 2.22, also for chromosome 16, between D16S415 and D16S503 (under a model of recessive inheritance). Additional areas of interest were identified on chromosomes 9, 14, and 18.
CONCLUSIONS: These findings meet conservative criteria for "suggestive" linkage. The gene encoding the norepinephrine transporter protein (SLC6A2) maps to this broad region, making SLC6A2 both a positional and physiological candidate for influencing social phobia risk. To the authors' knowledge, this is the first complete linkage genome scan for this disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14702251     DOI: 10.1176/appi.ajp.161.1.59

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

1.  Linkage analysis of alternative anxiety phenotypes in multiply affected panic disorder families.

Authors:  Abby J Fyer; Ramiro Costa; Fatemeh Haghighi; Mark W Logue; James A Knowles; Myrna M Weissman; Susan E Hodge; Steven P Hamilton
Journal:  Psychiatr Genet       Date:  2012-06       Impact factor: 2.458

Review 2.  Familial risk factors in social anxiety disorder: calling for a family-oriented approach for targeted prevention and early intervention.

Authors:  Susanne Knappe; Katja Beesdo-Baum; Hans-Ulrich Wittchen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-10-06       Impact factor: 4.785

3.  Influence of RGS2 on sertraline treatment for social anxiety disorder.

Authors:  Murray B Stein; Aparna Keshaviah; Stephen A Haddad; Michael Van Ameringen; Naomi M Simon; Mark H Pollack; Jordan W Smoller
Journal:  Neuropsychopharmacology       Date:  2013-10-24       Impact factor: 7.853

Review 4.  Imaging genomics applied to anxiety, stress response, and resiliency.

Authors:  Ke Xu; Monique Ernst; David Goldman
Journal:  Neuroinformatics       Date:  2006

5.  Genetic risk variants for social anxiety.

Authors:  Murray B Stein; Chia-Yen Chen; Sonia Jain; Kevin P Jensen; Feng He; Steven G Heeringa; Ronald C Kessler; Adam Maihofer; Matthew K Nock; Stephan Ripke; Xiaoying Sun; Michael L Thomas; Robert J Ursano; Jordan W Smoller; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-03       Impact factor: 3.568

6.  Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus.

Authors:  Belhassen Kaabi; Joel Gelernter; Scott W Woods; Andrew Goddard; Grier P Page; Robert C Elston
Journal:  Am J Hum Genet       Date:  2006-01-26       Impact factor: 11.025

7.  Inhibiting activator protein-1 activity alters cocaine-induced gene expression and potentiates sensitization.

Authors:  R F Paletzki; M V Myakishev; O Polesskaya; A Orosz; S E Hyman; C Vinson
Journal:  Neuroscience       Date:  2008-02-07       Impact factor: 3.590

8.  Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.

Authors:  H M Fentress; R Klar; J J Krueger; T Sabb; S N Redmon; N M Wallace; J K Shirey-Rice; M K Hahn
Journal:  Genes Brain Behav       Date:  2013-10-09       Impact factor: 3.449

9.  Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype.

Authors:  C M Middeldorp; J-J Hottenga; P E Slagboom; P F Sullivan; E J C de Geus; D Posthuma; G Willemsen; D I Boomsma
Journal:  Mol Psychiatry       Date:  2007-08-14       Impact factor: 15.992

10.  The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders.

Authors:  Jocelien D A Olivier; Christiaan H Vinkers; Berend Olivier
Journal:  Front Pharmacol       Date:  2013-06-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.